Search by Drug Name or NDC
NDC 69396-0033-18 Hemorrhoidal Cream 14.4; 15; .25; 1 g/100g; g/100g; g/100g; g/100g Details
Hemorrhoidal Cream 14.4; 15; .25; 1 g/100g; g/100g; g/100g; g/100g
Hemorrhoidal Cream is a TOPICAL CREAM in the HUMAN OTC DRUG category. It is labeled and distributed by Trifecta Pharmaceuticals Usa Llc. The primary component is GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE.
Product Information
NDC | 69396-0033 |
---|---|
Product ID | 69396-033_f276d390-8f30-8921-e053-2a95a90a0f2d |
Associated GPIs | 89992004743720 |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Hemorrhoidal Cream |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Glycerol, Phenylephine, Pramoxine, Petrolatum |
Product Type | HUMAN OTC DRUG |
Dosage Form | CREAM |
Route | TOPICAL |
Active Ingredient Strength | 14.4; 15; .25; 1 |
Active Ingredient Units | g/100g; g/100g; g/100g; g/100g |
Substance Name | GLYCERIN; PETROLATUM; PHENYLEPHRINE HYDROCHLORIDE; PRAMOXINE HYDROCHLORIDE |
Labeler Name | Trifecta Pharmaceuticals Usa Llc |
Pharmaceutical Class | Adrenergic alpha1-Agonists [MoA], Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC], alpha-1 Adrenergic Agonist [EPC] |
DEA Schedule | n/a |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part346 |
Listing Certified Through | 2024-12-31 |
Package
NDC 69396-0033-18 (69396003318)
NDC Package Code | 69396-033-18 |
---|---|
Billing NDC | 69396003318 |
Package | 1 TUBE in 1 BOX (69396-033-18) / 51 g in 1 TUBE |
Marketing Start Date | 2019-01-25 |
NDC Exclude Flag | N |
Pricing Information | N/A |